Evaluating Dentsply Sirona: Insights From 8 Financial Analysts
Portfolio Pulse from Benzinga Insights
Dentsply Sirona (NASDAQ:XRAY), a major dental equipment manufacturer, has been analyzed by 8 financial analysts, showing a mix of bullish to bearish sentiments. The average 12-month price target is $37.88, down 9.81% from the previous $42.00. Analysts have adjusted their ratings and price targets in response to market dynamics and company performance, with several lowering their targets. Despite its size, Dentsply Sirona faces revenue growth challenges, below-average net margin, ROE, and ROA, but maintains a sound debt-to-equity ratio.
January 09, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Dentsply Sirona's stock may experience short-term volatility due to mixed analyst ratings and downward revisions in price targets. The company's challenges in revenue growth, profitability, and asset utilization could weigh on investor sentiment.
The mixed analyst ratings and recent downward adjustments in price targets suggest uncertainty about Dentsply Sirona's future performance. While the company has a sound debt structure, its below-average profitability and efficiency metrics could deter investors, leading to potential short-term volatility in the stock price. However, the impact is not decidedly negative or positive, hence the neutral score.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100